Alnylam Pharma (ALNY) Tops Q4 EPS by 2c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $224.60 -1.77%
Financial Fact:
Total operating expenses: 101.16M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total operating expenses: 101.16M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q4 EPS of ($1.32), $0.02 better than the analyst estimate of ($1.34). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $10.95 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- The LGL Group (LGL) Misses Q2 EPS by 8c
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
